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Shypertension (HT), and metabolic syndromes (MS). The relation between TB levels
and in-hospital and long-term outcomes in patients with ST-segment elevation
myocardial infarction (STEMI) who undergo primary percutaneous coronary inter-
vention (PCI) is not known. Data from 1624 consecutive patients with STEMI who
underwent primary PCI were evaluated. TB was measured after primary PCI, and the
study population was divided into tertiles. A high TB group (n¼450) was deﬁned as
a value in the upper third tertile (>0.9 mg/dl) and a low bilirubin group (n¼1174), as
any value in the lower two tertiles (0.9 mg/dl). In-hospital mortality rate was
signiﬁcantly higher in the high TB group than in the low one (4% vs. 1.5%, p¼0.003). In
multivariate analyses, a signiﬁcant association was noted between high TB levels and
adjusted risk of in-hospital cardiovascular mortality (odds ratio: 2.67, 95% conﬁdence
interval (CI): 1.38–5.2; p¼0.004). In receiver operating characteristic curve analysis,
a TB value>0.90mg/dl was identiﬁed as an effective cut-point in STEMI for in-hospital
cardiovascular mortality (area under curve ¼0.66, 95% CI: 0.55–0.76, p¼0.001). The
mean follow-up timewas 26.2months. There were no differences in long-termmortality
rates between the two groups. In conclusion, high TB is independently associated with
in-hospital adverse outcomes in patients with STEMI who undergo primary PCI.
However, there was no association with long-term mortality.
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Association between Admission Mean Platelet Volume and ST Segment
Resolution after Thrombolytic Therapy for Acute Myocardial Infarction
Özgür Kırbas¸, Özge Kurmus¸, Cemal Köseoglu, Sina Ali, Recai Alemdar, Bilge Duran,
Mehmet Bilge
Cardiology Clinic, Atatürk Education and Research Hospital, Ankara
Objective: Mean platelet volume (MPV) is one of the indices of platelet reactivity and
has been shown to be related to impaired angiographic reperfusion in ST-segment
elevation myocardial infarction (STEMI) patients who treated with primary angioplasty
or thrombolytics. However data regarding MPV and its association with ST -segment
resolution; an indicator of epicardial and tissue level reperfusion in the setting of STEMI
are limited. In this study, we aimed to investigate whether MPV on admission is asso-
ciated with ST -segment resolution in STEMI patients treated with thrombolytics.
Methods: We retrospectively evaluated 232 consecutive patients with a diagnosis of
ﬁrst STEMI who were administered thrombolytic therapy within 12 hours of onset of
chest pain. ST segment resolution based on baseline and 90 minute electrocardiogra-
phies were measured. Patients were grouped into two as with >50% and 50% ST
-segment resolution. AdmissionMPVwasmeasured and compared between two groups.
Results: Admission MPV was higher in patients with 50% ST -segment resolution
than patients with >50% ST -segment resolution (9,91,3 ﬂ vs 8,51,1 ﬂ respec-
tively, p<0,001). The receiver operating characteristic analysis yielded a cutoff value
of 9,3 fL to predict ST -segment resolution, with sensitivity and speciﬁty being 66,7%
and 77,9%, respectively. In-hospital mortality rate was high in patients with 50%
ST-segment resolution (p¼0.002).
Conclusions: In conclusion, our study demonstrates for the ﬁrst time, to the best of
our knowledge, that MPV is an independent predictor of ST segment resolution in
STEMI patients treated with thrombolytics. These ﬁndings may serve to the knowl-
edge of the potential importance of MPV in the successful thrombolysis and prognosis
after a cardiovascular event.
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16-kDa Prolactin Promotes Cardiac Ischemia/Reperfusion Injury
Aylin Hatice Yamac
Bezmialem Üniversitesi Hastanesi, Istanbul
The recent discovery that anti-angiogenic, pro-apoptotic and pro-inﬂammatory N-
terminal 16-kDa prolactin subform (16-kDa Prl) is generated under enhanced oxida-
tive stress and yielding adverse cardiac effects, prompted us to investigate the
potential role of prolactin and its cleaved 16-kDa form in myocardial ischemia/
reperfusion (I/R) injury.
In the current study we demonstrate that enhanced levels of serum prolactin (Prl)
and cathepsin D (CD) activity in patients with acute myocardial infarction (AMI) were
associated with the generation of N-terminal 16-kDa subform.
In a murine model of myocardial I/R with previous LAD (left anterior descending
artery) ligation for 50 minutes, blockage of endogenous Prl release by the dopamine
D2 receptor agonist bromocriptine limited infarct size 24 hours post-reperfusion and
preserved left ventricular (LV) function after 14 days of reperfusion.
Additionally, we demonstrate that after blockage of endogenous Prl release, the
subsequent application of a recombinant mutant, prolactin isoform, which is notJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAcleaved into the 16-kDa subform, signiﬁcantly limited the extent of cardiac injury
compared to the well-cleaved corresponding wildtype prolactin isoform 24 hours post-
reperfusion.
I/R injury-induced up-regulation of pro-inﬂammatory mediators (e.g. TNF-a, CCL-
2, CXCL2) and extravasation of inﬂammatory inﬁltrates were signiﬁcantly reduced in
bromocriptine treated mice than untreated controls.
The bromocriptine induced cardiac protection was mainly addicted to inhibition of
16-kDa Prl formation, as myocardium treated with the mutant prolactin isoform dis-
played substantially less inﬂammatory cell inﬁltration and cytokine expression than
myocardium treated with the wildtype prolactin isoform.
In addition, we discovered that recombinant 16-kDa Prl markedly induced the
expression of proinﬂammatory cytokines via activation of NF-kB signalling in
neonatal rat cardiomyocytes.
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Can Fragmented QRS On 12 Derivation ECG Predict Thrombolytic Therapy
Success In Acute ST Elevated Myocardial Infarction?
Zülkif Tanrıverdi1, Mustafa Aytek S¸ims¸ek2, Barıs¸ Ünal1, Hüseyin Dursun1,
Ömer Kozan1, Dayimi Kaya1
1Dokuz Eylul University Hospital Cardiology Department, _Izmir, 2Nevs¸ehir I. S¸evki
Atasagun State Hospital Cardiology Department, Nevs¸ehir
Objective: FragmentedQRS (fQRS) on surface ECG of patients admittedwith acute ST
elevated myocardial infarction (STEMI) is shown to be related with poor prognosis in
several studies. However there is no study so far evaluated the relationship between
presence of fQRS and successful reperfusion with thrombolytic therapy in this group of
patients. The aim of our study is to determine whether fQRS can be used as a predictor of
thrombolytic therapy response in patients admitting for the ﬁrst time with STEMI.
Material-Methods: 116 patients admitted Dokuz Eylul University Hospital Cardi-
ology Department for the ﬁrst time with STEMI and treated with thrombolytic therapy
between 01 january 2009 and 01 july 2011 are included in our study. Patients having
ECG ﬁndings that can be misdiagnosed as fQRS [ incomplete right bundle branch
block pattern in V1, pacemaker rhythm, wide QRS complex (QRS >120 ms)] and
with CABG history are excluded. ECG recordings on admission, at the beginning,
30th, 60th, 90th minutes of thrombolytic therapy and in 48 hours of admission are
obtained. Presence of fQRS is deﬁned as presence of more than one R wave pattern or
notching on R or S waves in neighbouring 2 derivations (Figure 1). Successful
reperfusion is deﬁned as over 50% resolution in the highest ST segment elevated
derivation on the ECG taken in 90th minute of reperfusion therapy.
Findings: fQRS was present in 38.8% of patients (45 patients) included in our study.
For patients with and without fQRS, there was no signiﬁcant difference in myocardial
infarction (MI) localization (anterior MI: 40% vs 35.2%, p>0.05) and mean door to
needle time (29.19.4 vs. 26.98.1, p>0.05). But there was 28.4 % (27/95) fQRS in
patients with successful reperfusion with thrombolytic therapy compared to 85.7%
(18/21) in patients with failed reperfusion with thrombolytic therapy (p<0.001)
(Figure 2). In addition to these ﬁndings patientys with fQRS compared to ones without
it are older (6612 vs 6110, p¼0.02), have more prolonged QRS durations
(108.449.16 ms vs. 102.259.63 ms, p¼0.001), have higher leukocyte counts
(12.6203.315 vs. 10.596 2.887, p¼0.001), have lower left ventricle ejection
fraction ((35.566.84% vs 47.965.64%, p<0.001) and have higher maximum
troponin levels (60.6029.62 vs 30.9114.80, p<0.01) (Table 1).
Results: Presence of fQRS in acute STEMI is not relatedwithMI localization and timing
of thrombolytic therapy. However fQRS on surface ECG of patients admitted with
acute STEMI can predict the failure of thrombolytic therapy. Also presence of fQRS can
help to determine high risk patients with broader myocardial tissue under threat.LS C21
Table 1. Comparison Of Distinctive Features of PatientsWith andWithout fQRS
(HT: hypertension, DM: diabetes mellitus, HL: hyperlipidemia, SBP: systolic blood pressure,
DBP: diastolic blood pressure, LVEF: left ventricular ejection fraction, HBG: hemoglobin, WBC:
white blood cell count, MPV: mean platelet volume, PLT: platelet count, BUN: blood urea
nitrogen, LDL: low density lipoprotein, HDL: high density lipoprotein, CK-MB: creatinine kinase-
muscle band, MI: myocardial infarction)
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PCI vs Optimal Medical Therapy - The Other Side of the Coin: Medication
Adherence
Cüneyt Koças¸, Okay Abaci, Veysel Oktay, Ugur Coskun, Cem Bostan, Ahmet Yildiz,
Alev Arat Ozkan, Tevﬁk Gurmen, Murat Ersanli
Cardiology Institute of Istanbul University, Istanbul
There are many randomized controlled trials comparing outcomes for Percutaneous
coronary intervention (PCI) and optimal medical therapy alone (OMT) for stable coronary
artery disease patients whereas little is known about medication adherence PCI versus
OMT in a setting apart from randomized controlled trials. Although medication adherence
in randomized controlled trials like COURAGE is quite high, in real life these rates are
lower. In this study of 232 documented CAD (coronary artery disease) patients, we
compared statin, beta blocker and ACE-inhibitors adherence during six-month follow-up
between patients treated with PCI and those receiving medical therapy alone. Medication
adherence was measured by National reimbursement database records Of the 232 patients
who survived to the 6-month followup, the prespeciﬁed primary end point of percentage of
patients adherent by prescription records were 33.8% (n¼27) in OMT group and 53.6%
(n¼82) in PCI group, p¼0.004 (Figure 1). Analysis for the individual medication classes
revealed similar results for beta blockers (86.0% in PCI group vs 72.5% in OMT group,
p¼0.006) and statins (64.5% in PCI group vs 44.0% in OMT group, p¼0.003).
Adherence to ACE inhibitors was also higher in PCI group without statistical
signiﬁcance (77.6% vs 69.3%, p¼0.17). In the present study we demonstrated that
medication adherence to evidence based therapies in stable coronary artery disease
patients in PCI group is signiﬁcantly higher than OMT group.C22 JACC VOP-057
Relation of Neutrophil/Lymphocyte Ratio to GRACE Risk Score to In-hospital
Cardiac Events in Patients with ST-Elevated Myocardial Infarction
Ramazan Can Öncel1, Mustafa Uçar1, Mustafa Serkan Karakas¸2, Barıs¸ Akdemir3,
Atakan Yanıkoglu1, Ali Rıza Gülcan4, Reﬁk Emre Altekin1, _Ibrahim Demir1
1Akdeniz University Medical Faculty, Department of Cardiology, Antalya, 2Nigde
State Hospital, Department of Cardiology, Nigde, 3Burdur State Hospital,
Department of Cardiology, Burdur, 4Sanliurfa Research and Education Hospital,
Department of Cardiology, Sanliurfa
Objectives: Neutrophil/Lymphocyte ratio (NLR) is being increasingly used as
a marker for cardiovascular risk assessment and as a prognostic tool in ST-elevated
myocardial infarction (STEMI). In this study, we aimed to investigate the association
of the NLR with GRACE risk score and in-hospital major advanced cardiac events in
patients with STEMI undergoing primary percutaneous coronary intervention (PCI).
Material/Methods: We analyzed 101 consecutive STEMI patents treated with
primary PCI. Patients were divided into 3 groups by use of GRACE risk score. The
NLR was calculated as a part of automated complete blood count. The association
between NLR and GRACE risk score was assessed.
Results: Baseline Characteristics.
The study population consisted of 101 consecutive STEMI patients. 80.2%of patients
were male and mean age of patients was 57.9712.24 years. 42 patients were hyper-
tensive,23 patients were diabetic,34 patients were hyperlipidemic and 57 were smoker.
According to the GRACE risk score,21 patients had low GRACE risk scores,48
patients had intermediate GRACE risk scores, 32 patients had high GRACE risk
scores. Demographic and biochemical characteristics of patients in GRACE risk score
groups are shown in table 1. The NLR showed a proportional increase correlated with
GRACE risk score (p<0.001) (Table 1, Figure 1).
Correlation With In-Hospital Events
During the in-hospital period, 11 patients (10.9%) presented cardiac events (3 cardiac
death, 2 reinfarction, 6 new-onset heart failure). These patients hadmore advancedKillip
functional class and higher GRACE risk score. The occurrence of in hospital cardiac
death, reinfarction or new-onset heart failure was signiﬁcantly related to NLR at
admission (8.181.16 vs. 3.071.77, p<0.001). Likewise,NLR andGRACE risk score
showed a signiﬁcant positive correlation (r¼0.803, p<0.001) (Figure 2).
Multivariate Analysis
For in hospital cardiac events; N/L ratio,blood glucose level upon admission,
troponin level at admission and in hospital GRACE death point were analyzed using
a multivariate logistic regression model. The NLR was the only independent predictor
of in-hospital cardiac events (odds ratio 3.63, conﬁdence interval 95%: 1.31-10.04,
p¼0.013) (Table 2).
Discussion: NLR has recently emerged as a potential new biomarker which singles
out individuals at risk for future cardiovascular events in STEMI patients. Unlike
many other inﬂammatory markers and bioassays, NLR is an inexpensive and readily
available marker that provides an additional level of risk scores in predicting inhos-
pital and long-term outcomes. Although the GRACE risk score is routinely used for
stratiﬁcation of patients with acute coronary syndrome, NLR may provide additional
prognostic value. Increased NLR is independently associated with a higher rate of in-
hospital cardiac events. The determination of NLR for risk stratiﬁcation of STEMI
patients during hospitalization may be useful.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
